March, 2019
Roche/Genentech Amends GENERATION-HD1 Study
Posted on March 28, 2019
On Thursday, March 21st, Roche/Genentech released a Community Statement about changes to the GENERATION-HD1 study, the clinical trial testing huntingtin-lowering…
Read MoreInterview with Roche Representatives
Posted on March 21, 2019
A few weeks ago we blogged about the Annual CHDI Huntington’s disease Therapeutics Conference in Palm Springs, California. This week,…
Read MoreGene Therapy 101
Posted on March 14, 2019
In addition to ongoing clinical trials of Roche/Genentech and Wave huntingtin-lowering therapies, a number of other companies are developing drugs…
Read MoreAnnual CHDI Huntington’s Disease Therapeutics Conference
Posted on March 7, 2019
This week in Palm Springs, California, CHDI Foundation hosted the 14th Annual HD Therapeutics Conference. This yearly conference draws academic…
Read More